World Drug Report

World Drug Report
Name	World Drug Report
Caption	Annual global drug market assessment
Publisher	United Nations Office on Drugs and Crime
Country	United Nations
Language	English
First	1997
Frequency	Annual

World Drug Report

The World Drug Report is an annual assessment produced by the United Nations Office on Drugs and Crime that synthesizes data on illicit drug markets, production, trafficking, consumption, and policy responses. It draws on information from member states, international agencies, scientific publications, and law enforcement to inform multilateral forums such as the United Nations General Assembly, the United Nations Commission on Narcotic Drugs, and the Conference of the Parties to the Single Convention on Narcotic Drugs. The report is widely cited by institutions including the World Health Organization, the International Narcotics Control Board, the World Bank, the International Monetary Fund, and major non-governmental organizations such as Médecins Sans Frontières.

Overview

The report provides estimates of cultivation, manufacture, trafficking routes, retail markets, prevalence of use, and health harms associated with substances such as cannabis, cocaine, opioid, including heroin, synthetic opioids like fentanyl, amphetamines, and ecstasy (MDMA). It also addresses precursor chemicals regulated under the 1988 United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, links to organized crime groups such as cartels implicated in the Mexican Drug War and drug syndicates in the Golden Triangle (Southeast Asia), and regional patterns in the Andean States, Afghanistan, Southeast Asia, West Africa, Europe, North America, Central Asia, Australia, and Caribbean. Analyses reference institutions like the European Monitoring Centre for Drugs and Drug Addiction, the Organization of American States, and the African Union.

History and publication

The series traces roots to post-Single Convention on Narcotic Drugs international efforts and periodic reports by the United Nations Economic and Social Council and the International Narcotics Control Board. Milestones include methodological changes after high-profile events such as the Opium poppy cultivation in Afghanistan surge, the rise of the Mexican Drug War, the discovery of synthetic opioid clusters in the United States, and policy shifts exemplified by the Uruguay cannabis law and the Canada Cannabis Act. Publication has involved collaboration with agencies like the United Nations Development Programme, the United Nations Children's Fund, the United Nations Entity for Gender Equality and the Empowerment of Women, and academic partners at universities including Columbia University, University College London, University of Oxford, Johns Hopkins University, Imperial College London, and Massachusetts Institute of Technology.

Methodology and data sources

Methodology combines national surveys such as the National Survey on Drug Use and Health and the European School Survey Project on Alcohol and Other Drugs with seizure data from customs and police agencies like U.S. Customs and Border Protection, Royal Canadian Mounted Police, Europol, INTERPOL, and the Australian Federal Police. It integrates satellite imagery analysis used in remote sensing studies of cultivation in regions like Myanmar and Colombia, forensic toxicology results from laboratories including the National Forensic Laboratory Service and the Forensic Science Service (UK), and financial intelligence reports from bodies such as the Financial Action Task Force and national financial intelligence units like the Financial Crimes Enforcement Network. Public health metrics incorporate data from the World Health Organization Global Health Observatory, the Joint United Nations Programme on HIV/AIDS, the Global Burden of Disease Study, and hospital data from systems such as the National Health Service (England) and the Centers for Disease Control and Prevention.

Key findings and trends

Recent editions highlight the global expansion of synthetic drug manufacture in chemical hubs in China, India, and parts of Europe, the increasing prominence of fentanyl and analogs affecting overdose patterns in the United States and Canada, and shifts in coca cultivation across Bolivia, Peru, and Colombia. Other documented trends include growth in stimulant markets linked to trafficking networks across West Africa to Europe, diversification of synthetic opioid supply via darknet platforms such as marketplaces like Silk Road, and the emergence of non-medical benzodiazepine markets in regions including Central Asia. The report maps links between drug markets and environmental impacts in regions affected by deforestation in the Amazon rainforest and captures policy outcomes following regulatory changes in Portugal, Netherlands, and Thailand.

Impact and reception

Policymakers in bodies like the European Commission, the Organization of American States Inter-American Drug Abuse Control Commission, and national legislatures frequently cite the report when designing law enforcement, public health, and development interventions. International financial institutions such as the World Bank and the International Monetary Fund reference its estimates in analyses of illicit financial flows and development impacts in countries such as Afghanistan and Venezuela. Civil society organizations including Harm Reduction International and International Drug Policy Consortium use its data in advocacy. Academic researchers at institutions like Harvard University, Yale University, Stanford University, University of Toronto, and Australian National University analyze the report for trend projections.

Criticisms and controversies

Critics from NGOs such as the International Drug Policy Consortium and scholars associated with Transnational Institute argue that reliance on seizure data and self-reported surveys can produce biased estimates and may undercount marginalized populations in places like Sub-Saharan Africa and informal settlements in Brazil. Debates have occurred around interpretations of data in high-profile policy discussions involving the United Nations General Assembly Special Session on the World Drug Problem (2016) and national reforms in Uruguay and Canada. Law enforcement agencies including the Drug Enforcement Administration and civil liberties groups such as Amnesty International have clashed over portrayals of interdiction effectiveness. Methodological disputes reference statistical techniques used in studies by groups like the Institute for Criminal Policy Research and controversies over precursor chemical regulation have involved companies and governments in Belgium, Netherlands, and India.

Category:Reports by the United Nations Office on Drugs and Crime